| CLA1653 |
|
1446419-85-7 |
依維蘇單抗
Anti-Human ANGPTL3 Monoclonal Antibody(Evinacumab)
-
95+%
|
需詢價(jià) |
|
|
|
|
| CLA1188 |
|
914613-48-2 |
卡那奴單抗
Anti-Human IL-1B Monoclonal Antibody(Canakinumab)
3-5days
95+%
|
￥5000.00 |
— |
|
|
|
| CLA1031 |
|
347396-82-1 |
雷珠單抗
Ranibizumab (Anti-VEGFA)
3-5days
95+%
|
￥7500.00 |
— |
|
|
|
| CLA1032 |
|
339186-68-4 |
馬妥珠單抗
Matuzumab
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1023 |
|
375823-41-9 |
托珠單抗 (anti-IL-6R)
Tocilizumab (anti-IL-6R); MRA
3-5days
95+%
|
￥5200.00 |
— |
|
|
|
| CLA1015 |
|
219685-50-4 |
依庫麗單抗; 依庫珠單抗
Eculizumab
In-stock
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1012 |
|
615258-40-7 |
地諾單抗 | 狄諾塞麥 | 地舒單抗
Denosumab (anti-RANK ligand) | AMG-162
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1008 |
|
216974-75-3 |
貝伐單抗
Bevacizumab (anti-VEGF) | RhuMab VEGF
3-5days
95+%
|
￥1500.00 |
— |
|
|
|
| CLA1006 |
|
331731-18-1 |
阿達(dá)木單抗
Adalimumab (anti-TNF-alpha)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1002 |
|
946414-94-4 |
納武單抗 (anti-PD-1); 尼魯單抗
Nivolumab (anti-PD-1)
3-5days
95+%
|
￥2000.00 |
— |
|
|
|
| CLA1057 |
|
143090-92-0 |
阿那白滯素
Anakinra (IL-1Ra) | Raleukin | AMG-719
3-5days
98+%
|
￥2000.00 |
C759H1186N208O232S10 |
|
|
|
| CLA1009 |
|
174722-31-7 |
利妥昔單抗
Anti-CD20 (rituximab biosimilar) mAb
3-5days
95+%
|
￥2600.00 |
— |
|
|
|
| CLA1005 |
|
205923-56-4 |
西妥昔單抗
Cetuximab(C225),Stock solution
3-5days
95+%
|
￥3000.00 |
C6484H10042N1732O2023S36 |
|
|
|
| CLA1003 |
|
180288-69-1 |
曲妥珠單抗
Trastuzumab (anti-HER2)
3-5days
95+%
|
￥2000.00 |
C6470H10012N1726O2013S42 |
|
|
|
